Gaudium IVF & Women Health Ltd launched its ₹165 crores IPO on February 20, 2025. The bidding window for the IPO closed yesterday, Tuesday, February 24, 2025. The allotment date for the Gaudium IVF & Women Health IPO is finalised as February 25, 2026, and the tentative listing date is fixed as February 27, 2026. The shares will be listed on both NSE and BSE.

Steps to Check Gaudium IVF IPO Allotment Status on NSE

Here is the process to check Gaudium IVF & Women Health IPO Allotment Status on NSE:

Open the Application Status page of NSE here.
Choose 'Equity & SME IPO bid details'.
Select 'Gaudium IVF & Women Health Ltd’ from the list of companies.
Enter your IPO application number and PAN details.
Click on the submit button to check the details of the share allotment.

Steps to Check Gaudium IVF IPO Allotment Status Online On BSE

Here is the process to check Gaudium IVF & Women Health IPO Allotment Status on BSE:

Click here to visit the application status page.
In Issue Type, “Equity”.
In Issue Name, select “Gaudium IVF & Women Health Ltd”.
Enter your “Application No.” or “PAN No.”
Click on “I am not a robot”.
Click “Submit”.

Steps to Check Gaudium IVF IPO Allotment Status on Bigshare Services Pvt Ltd (Registrar to the issue)

Here is the process to check Gaudium IVF & Women Health IPO Allotment Status on the registrar’s website:

Visit the Bigshare Services’ IPO allotment status page here.
Click any of the server links.
In Company Selection, select “Gaudium IVF & Women Health Ltd”
Enter any of the following details:
- Application Number,
- Beneficiary ID or
- PAN.
Enter the captcha and click “Search.”

Gaudium IVF & Women Health IPO - Issue Details

Issue Size: Gaudium IVF & Women Health IPO was a bookbuild issue of ₹165.00 crores. It consisted of a combination of fresh issue of 1.14 crore shares aggregating to ₹90.00 crores and offer for sale (OFS) of 0.95 crore shares aggregating to ₹75.00 crores.
Price Band: ₹75 to ₹79 per share
Minimum lot size: 189
Minimum investment for retail individual investors (RIIs): ₹14,175
Book-running lead managers: Sarthi Capital Advisors Private Limited
Registrar: Bigshare Services Private Limited is the registrar

Gaudium IVF & Women Health IPO Overall Subscription Status

[February 24, 2026, 7 PM]

On Day 3, Gaudium IVF & Women Health IPO saw an overall subscription of 7.27 times as per NSE data on February 24, 2026, 07:00 pm. The public issue was subscribed to 7.60 times by Retail Individual Investors (RIIs), 14.05 times by Non-Institutional Investors (NIIs), and 1.62 times by Qualified Institutional Buyers (QIBs).

Explore other upcoming IPOs on BSE and NSE.

Gaudium IVF & Women Health Ltd GMP

As per media reports, the Grey Market Premium (GMP) of Gaudium IVF & Women Health Ltd is reported at ₹0.

Check out newly listed IPOs on BSE and NSE.

Gaudium IVF & Women Health Ltd - Business Overview

Gaudium IVF & Women Health Ltd is a Delhi-based healthcare company founded in March 2015 by Dr. Manika Khanna. It specialises in fertility and women’s health services, offering treatments such as In Vitro Fertilization (IVF), ICSI, IUI, genetic testing (PGT), male infertility care, and high-risk pregnancy support through a hub-and-spoke network of clinics across India.

The company operates over 30 centres, including 7 hub centres and 28 spoke units, providing advanced assisted reproductive technologies and comprehensive women’s health care in major cities. In FY25 (year ended March 31, 2025), the company reported a revenue of about ₹70.96 crore, up from ₹48.15 crore in FY24, and profit after tax (PAT) of around ₹19.13 crore, nearly doubling year-on-year.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here

Do you like this edition?